To further evaluate relationships among USP22 and sorafenib resistance, expression of ABCC1, USP22, and SIRT1 in 6 HCC cell lines were analyzed by RT-qPCR and western blotting (Figure 1B,C). Here, USP22 is linked to hepatocellular carcinoma.